Breast health

BI-RADS 3: What 'Probably Benign' Really Means

Save

BI-RADS 3 means probably benign, with more than a 98% chance the finding is not cancer. The standard plan is short-interval follow-up imaging at about 6 months rather than immediate biopsy. If the finding stays stable over roughly 2 years it becomes benign; if it changes, biopsy is considered.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What does BI-RADS 3 mean?

BI-RADS 3 means a finding looks almost certainly harmless, and by the standardized definition more than 98% of category 3 results are not cancer. Under the American College of Radiology system, a 3 sits between a clearly benign 2 and a suspicious 4, reserved for findings with a very low but not zero chance of cancer. According to the National Cancer Institute, most abnormal mammogram findings are benign, which is the backdrop for this category 1. The result usually appears alongside your full BI-RADS 0-to-6 report. A 3 is a reassuring finding paired with a plan to keep an eye on it, which is why it comes with a follow-up date rather than a referral.

Why watch instead of biopsy right away?

Short-interval follow-up spares most people an invasive biopsy for a finding that is very unlikely to be cancer. Biopsying every probably-benign result would mean many procedures, with their small risks of bleeding and bruising, to confirm what is benign more than 98% of the time. According to the National Cancer Institute, more testing carries its own harms, so surveillance is a deliberate trade-off 1. Watching also catches the rare finding that does change, early enough to act.

According to the American College of Obstetricians and Gynecologists, tailoring workup to actual risk is a core screening principle 2. The plan reflects the low odds, not a lack of care. Many centers use ultrasound for the recheck when the finding was first seen that way.

What does the follow-up schedule look like?

A typical BI-RADS 3 pathway is a repeat mammogram or ultrasound at about 6 months, then again at intervals over roughly 2 years. If the finding stays stable across that window, the radiologist downgrades it to a benign 2, and you return to your routine mammogram schedule. Probably-benign findings are common in younger, premenopausal women with denser tissue, and a dense-breast pattern on your letter can be part of the picture. According to breast-screening guidelines, stability over time is strong evidence a finding is benign 2. The schedule is designed to confirm that stability without rushing to a biopsy.

When does a 3 become a 4?

A category 3 finding is upgraded to BI-RADS 4 if it grows, changes shape, or develops suspicious features on follow-up. At that point a biopsy is usually recommended to sample the tissue, since a 4 carries a 2% to 95% cancer risk. A new finding that first appears after menopause is watched more carefully than a long-stable one, because fresh changes matter more once density typically falls. A lump you can feel alongside a category 3 is also read differently. According to the National Cancer Institute, change over time is the signal radiologists watch for 1. Most 3s never move to a 4, and the upgrade, when it happens, usually surfaces at the first 6-month recheck.

When a probably-benign result needs a second look

A category 3 area that grows between visits, or new symptoms such as a lump, skin dimpling, or nipple change you notice while checking your breasts, is a reason to seek clinician review before the next scheduled scan. Keeping the 6-month and later follow-up appointments is what confirms a finding is truly benign. According to the American College of Obstetricians and Gynecologists, symptoms are evaluated regardless of a reassuring imaging category 2. Gale can help you keep the follow-up schedule straight and prepare questions for your clinician. Tracking each recheck in one place also makes it easy to see whether a finding has truly stayed stable.

Common questions

A category 3 finding is more than 98% likely to be benign, so significant worry is usually not warranted. The plan is watchful waiting with repeat imaging rather than biopsy, precisely because the odds of cancer are low.

Biopsying every probably-benign finding would mean many invasive procedures for results that are almost always benign. Short-interval follow-up catches the rare change early while sparing most people an unnecessary biopsy.

A typical pathway is repeat imaging at about 6 months, then at intervals over roughly 2 years. If the finding stays stable it is downgraded to benign; if it changes, the category is raised and a biopsy is considered.

That is a reasonable conversation to have. Some people prefer a biopsy for peace of mind, and a breast clinician can discuss the small risks and benefits of biopsy versus watchful waiting for your specific finding.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When a probably-benign result needs review

  • A category 3 area that grows or changes between follow-up scans is a reason to seek prompt clinician review
  • A new lump or thickening you can feel is a reason to contact your clinician rather than wait for the next scan
  • Skin dimpling, puckering, or a newly inverted nipple is a reason to arrange a clinical breast exam
  • Spontaneous bloody discharge from one nipple is a reason to seek clinician review

This article is general health education, not medical advice. Whether watchful waiting or biopsy fits your BI-RADS 3 finding depends on your images and history, and should be decided with a radiologist and your breast health clinician.

References

  1. 1.National Cancer Institute (PDQ Screening and Prevention Editorial Board) (2025). Breast Cancer Screening. National Cancer Institute (NCI), NIH. linkNCI patient screening page supporting that most abnormal mammogram findings are benign, that additional testing carries its own harms, and that change over time is what radiologists watch for
  2. 2.American College of Obstetricians and Gynecologists (2017). Practice Bulletin Number 179: Breast Cancer Risk Assessment and Screening in Average-Risk Women. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000002158ACOG guidance that workup should be tailored to actual risk, that stability over time supports a benign interpretation, and that symptoms are evaluated regardless of the imaging category

2 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy